BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

892 related articles for article (PubMed ID: 18565366)

  • 1. Vital pulp therapy with new materials for primary teeth: new directions and treatment perspectives.
    Fuks AB
    J Endod; 2008 Jul; 34(7 Suppl):S18-24. PubMed ID: 18565366
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vital pulp therapy with new materials for primary teeth: new directions and Treatment perspectives.
    Fuks AB
    Pediatr Dent; 2008; 30(3):211-9. PubMed ID: 18615986
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vital pulp therapy with new materials: new directions and treatment perspectives--permanent teeth.
    Witherspoon DE
    Pediatr Dent; 2008; 30(3):220-4. PubMed ID: 18615987
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vital pulp therapy with new materials: new directions and treatment perspectives--permanent teeth.
    Witherspoon DE
    J Endod; 2008 Jul; 34(7 Suppl):S25-8. PubMed ID: 18565368
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pulp treatment for extensive decay in primary teeth.
    Smaïl-Faugeron V; Glenny AM; Courson F; Durieux P; Muller-Bolla M; Fron Chabouis H
    Cochrane Database Syst Rev; 2018 May; 5(5):CD003220. PubMed ID: 29852056
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current concepts in vital pulpotomies in primary teeth.
    Castro A
    J Mich Dent Assoc; 2005 Jan; 87(1):26-8. PubMed ID: 15714830
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Maturogenesis of a cariously exposed immature permanent tooth using MTA for direct pulp capping: a case report.
    Patel R; Cohenca N
    Dent Traumatol; 2006 Dec; 22(6):328-33. PubMed ID: 17073926
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative evaluation of formocresol and mineral trioxide aggregate as pulpotomy agents in deciduous teeth.
    Srinivasan D; Jayanthi M
    Indian J Dent Res; 2011; 22(3):385-90. PubMed ID: 22048576
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of the formocresol versus mineral trioxide aggregate primary molar pulpotomy: a meta-analysis.
    Peng L; Ye L; Tan H; Zhou X
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2006 Dec; 102(6):e40-4. PubMed ID: 17138165
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Histological evaluation of mineral trioxide aggregate and calcium hydroxide in direct pulp capping of human immature permanent teeth.
    Sawicki L; Pameijer CH; Emerich K; Adamowicz-Klepalska B
    Am J Dent; 2008 Aug; 21(4):262-6. PubMed ID: 18795524
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term evaluation of pulpotomy in primary molars using mineral trioxide aggregate or formocresol.
    Holan G; Eidelman E; Fuks AB
    Pediatr Dent; 2005; 27(2):129-36. PubMed ID: 15926290
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management of traumatically injured pulps in immature teeth using MTA.
    Bakland LK
    J Calif Dent Assoc; 2000 Nov; 28(11):855-8. PubMed ID: 11811234
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Scanning electron microscopy evaluation of the hard tissue barrier after pulp capping with calcium hydroxide, mineral trioxide aggregate (MTA) or ProRoot MTA.
    Reston EG; de Souza Costa CA
    Aust Endod J; 2009 Aug; 35(2):78-84. PubMed ID: 19703080
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Success rates of mineral trioxide aggregate, ferric sulfate, and formocresol pulpotomies: a 24-month study.
    Erdem AP; Guven Y; Balli B; Ilhan B; Sepet E; Ulukapi I; Aktoren O
    Pediatr Dent; 2011; 33(2):165-70. PubMed ID: 21703067
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current trends in primary tooth pulp therapy.
    Haney KL
    J Okla Dent Assoc; 2007 Oct; 99(2):28-37; quiz 38. PubMed ID: 18019933
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biodentine used as a pulp-capping agent in primary pig teeth.
    Shayegan A; Jurysta C; Atash R; Petein M; Abbeele AV
    Pediatr Dent; 2012; 34(7):e202-8. PubMed ID: 23265156
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pulp treatment for extensive decay in primary teeth.
    Smaïl-Faugeron V; Courson F; Durieux P; Muller-Bolla M; Glenny AM; Fron Chabouis H
    Cochrane Database Syst Rev; 2014 Aug; (8):CD003220. PubMed ID: 25099759
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vital pulp therapy with mineral trioxide aggregate.
    Karabucak B; Li D; Lim J; Iqbal M
    Dent Traumatol; 2005 Aug; 21(4):240-3. PubMed ID: 16026533
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical, radiographic and histological analysis of the effects of mineral trioxide aggregate used in direct pulp capping and pulpotomies of primary teeth.
    Caicedo R; Abbott PV; Alongi DJ; Alarcon MY
    Aust Dent J; 2006 Dec; 51(4):297-305. PubMed ID: 17256303
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of mineral trioxide aggregate and formocresol as pulp medicaments for pulpotomies in primary molars.
    Noorollahian H
    Br Dent J; 2008 Jun; 204(11):E20. PubMed ID: 18425074
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 45.